Argininosuccinic aciduria: Recent pathophysiological insights and therapeutic prospects.

J Inherit Metab Dis 2019 Feb 5. Epub 2019 Feb 5.

Division of Metabolism and Children Research Centre (CRC), University Children's Hospital, Zurich, Switzerland.

The first patients affected by argininosuccinic aciduria (ASA) were reported 60 years ago. The clinical presentation was initially described as similar to other urea cycle defects, but increasing evidence has shown overtime an atypical systemic phenotype with a paradoxical observation, that is, a higher rate of neurological complications contrasting with a lower rate of hyperammonaemic episodes. The disappointing long-term clinical outcomes of many of the patients have challenged the current standard of care and therapeutic strategy, which aims to normalize plasma ammonia and arginine levels. Interrogations have raised about the benefit of newborn screening or liver transplantation on the neurological phenotype. Over the last decade, novel discoveries enabled by the generation of new transgenic argininosuccinate lyase (ASL)-deficient mouse models have been achieved, such as, a better understanding of ASL and its close interaction with nitric oxide metabolism, ASL physiological role outside the liver, and the pathophysiological role of oxidative/nitrosative stress or excessive arginine treatment. Here, we present a collaborative review, which highlights these recent discoveries and novel emerging concepts about ASL role in human physiology, ASA clinical phenotype and geographic prevalence, limits of current standard of care and newborn screening, pathophysiology of the disease, and emerging novel therapies. We propose recommendations for monitoring of ASA patients. Ongoing research aims to better understand the underlying pathogenic mechanisms of the systemic disease to design novel therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jimd.12047DOI Listing
February 2019
2 Reads

Publication Analysis

Top Keywords

novel therapies
8
newborn screening
8
current standard
8
standard care
8
argininosuccinic aciduria
8
argininosuccinate lyase
4
better understanding
4
understanding asl
4
achieved better
4
lyase asl-deficient
4
mouse models
4
asl close
4
models achieved
4
asl-deficient mouse
4
interaction nitric
4
physiological role
4
role liver
4
liver pathophysiological
4
pathophysiological role
4
asl physiological
4

References

(Supplied by CrossRef)
Argininosuccinate lyase deficiency
Nagamani SC et al.
Genet Med 2012
Enzymes of arginine and urea synthesis
Ratner S et al.
Adv Enzymol Relat Areas Mol Biol 1973
An appropriate concentration of arginine is required for normal root growth in rice
Xia J et al.
Plant Signal Behav 2014

Similar Publications